|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Health Policy and Ethics |
1 Veterans administration
2 UCLA
3 UCSD
* To whom correspondence should be addressed. E-mail: drpeterweiss{at}gmail.com.
| Abstract |
|---|
The Centers for Disease Control and Prevention has classified Bacillus anthracis, the causative organism of anthrax, as a category A potential bioterrorism agent.
There are critical shortcomings in the US anthrax vaccine program. Rather than depending on the private sector, the government must assume direct production of anthrax vaccine.
The development of a capacity capable of preemptive immunization of the public against anthrax should be considered.
Key Words: Government, Health Policy, Infections
This article has been cited by other articles:
![]() |
M. A. K. Ryan, T. C. Smith, C. J. Sevick, W. K. Honner, R. A. Loach, C. A. Moore, and J. D. Erickson Birth Defects among Infants Born to Women Who Received Anthrax Vaccine in Pregnancy Am. J. Epidemiol., August 15, 2008; 168(4): 434 - 442. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |